8 Patents
- US126007832026Anti-new York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) Antigen-binding Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US126007932026Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US125901682026Antigen-binding Molecules That Bind CD38 And/or CD28, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US122584122025Nucleic Acid Molecules Encoding Bispecific Anti-bcma X Anti-cd3 Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites - US121509592024Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US119053322024Antigen-binding Molecules That Bind CD38 And/or CD28, and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - 0 cites